Early results of combined valve replacement and coronary revascularisation

Fortyfive patients underwent combined valve replacement and coronary revascularisation from June 1987 to May 1993. Twentytwo patients underwent MVR and CABG, 21 patients A V Rand CABG and 2 had both aortic and mitral valve replacement in addition to CABG. Cold potassium blood cardioplegla was used for intraoperative myocardial protection in all the patients. Among those who underwent A V R and CABG, 3 patients died and 3 others died from among those who underwent MVR and CABG. Both patients who underwent double valve replacement and CABG did well. Rheumatic mitral lesions were the common indication for MVR in patients with combined mitral lesions and coronary artery diseases. This is in contrast to western patients, where ischaemic and degenerative lesions are more common.